Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome

Blood Adv. 2020 May 26;4(10):2119-2122. doi: 10.1182/bloodadvances.2020001626.
No abstract available

MeSH terms

  • Humans
  • Immunotherapy, Adoptive
  • Neurotoxicity Syndromes* / etiology
  • Receptors, Chimeric Antigen*
  • Steroids
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen
  • Steroids